John Wollobin
Analyst
Citizens
Equibles does not estimate personal net worth.
About John Wollobin
John Wollobin is recorded as Analyst at Citizens. John Wollobin has spoken on 3 earnings calls and 1 other investor event across 3 companies, most recently for DBV Technologies S.A. on October 28, 2026. Those appearances were for DBV Technologies S.A. (DBVT), Rhythm Pharmaceuticals, Inc. (RYTM) and Crinetics Pharmaceuticals, Inc.. The companies whose calls John Wollobin spoke on are classified in the Healthcare sector.
John Wollobin on recent calls
“I might have missed this, but can you discuss what the warning letter details included and what remediation activities are still ongoing? And then any thoughts on getting a second manufacturer to have redundant supply?”
“A couple from me, I might have missed this, Jen, but I think last update you said time to pay drug was about 60 to 90 days, and I was wondering if there was an update there.”
“Just wondering, without knowing the true context or size of these changes, any chance that this could get pushed to 4Q, or is this going to be relatively easy to maneuver through?”
“Just for one from me on Palisanofi, when we think about the unique prescriber base, do you have a sense of how many agro-mediculity patients those prescribers have under their just looking for some commentary about kind of the deepening of the prescribers as well as the broadening over time.”
Affiliation history
-
Citizens
Analyst
Transcript header (unverified)
Current
Company network
Crinetics Pharmaceuticals, Inc.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-05-07
Recent activity
-
-
-
-
Earnings call
Crinetics Pharmaceuticals, Inc. Q1 FY2026 Earnings Call
Crinetics Pharmaceuticals, Inc.